Status:
COMPLETED
Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home Births
Lead Sponsor:
Gynuity Health Projects
Collaborating Sponsors:
Aga Khan Health Services
Conditions:
Postpartum Hemorrhage (PPH)
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Misoprostol, a prostaglandin E1 that induces uterine contractions, has been proposed as a low cost, easy-to-use option for prevention and treatment of Postpartum Haemorrhage (PPH), especially in setti...
Eligibility Criteria
Inclusion
- Women must be pregnant
- Must be able to provide informed consent
- Must agree to have a community health worker present at the time of delivery
- Must agree to participate in a follow up interview by the study midwife
- Must agree to have pre and postpartum haemoglobin taken
Exclusion
- Women who do not meet the inclusion criteria
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01508429
Start Date
July 1 2012
End Date
February 1 2016
Last Update
July 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Home delivery setting
Darwaz, Ishkashim, Shugnan, Wakhan Districts, Badakshan Province, Afghanistan